secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001193125-23-245615
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences stockholders approve all proposals at 2023 annual meeting
-------------------------------------------------------------------------------

- Directors David Kupfer and Jan van Heek elected with ~3.25M and ~3.37M votes, respectively.
- Equity plan amendment approved to increase authorized shares by 700,000; 3.28M for, 577K against.
- Advisory vote on named executive officer compensation passed with 3.74M for, 71K against.
- Ratification of Deloitte & Touche as auditor for FY2023 approved with 5.06M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312523245615/0001193125-23-245615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312523245615/d558875d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-245615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer